Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

NCT: NCT06578741 · ACTIVE_NOT_RECRUITING

NCT IDNCT06578741
StatusACTIVE_NOT_RECRUITING
Start Date2024-11-25
Completion2036-06-01
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

This study aims to confirm that the benefit-risk assessment of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) remains positive in real-world use and to ensure the adequacy of the TAMBE Device training program.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑